Development of Predictive Biomarkers
Development of Predictive Biomarkers for the Rate of C-peptide Decline in Persons With Recent Onset Type 1 Diabetes
Sponsor: Benaroya Research Institute
A observational or N/A phase clinical study on Type1diabetes, this trial is completed. The trial is conducted by Benaroya Research Institute and has accumulated 14 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
-
Dec 2021 — May 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2021 — Dec 2021 [monthly]
Active Not Recruiting
▶ Show 9 earlier versions
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2019 — Aug 2020 [monthly]
Recruiting
-
Apr 2019 — Nov 2019 [monthly]
Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Benaroya Research Institute
- Juvenile Diabetes Research Foundation
- Medical College of Wisconsin
For direct contact, visit the study record on ClinicalTrials.gov .